Neuroimmunology is the study of how the nervous system and the immune system talk to each other, and its central finding over the past two decades has upended a longstanding assumption: that the brain operates in near-total isolation from the body’s immune defenses. The discovery of lymphatic vessels lining the brain’s membranes, the recognition that the brain’s resident immune cells sculpt neural circuits from birth, and the growing evidence that peripheral inflammation can rewire mood and cognition have turned neuroimmunology from a niche specialty into one of the most active frontiers in biomedical science. The implications stretch from Alzheimer’s disease and multiple sclerosis to depression, autism, and even normal aging.
The Brain Was Never Truly Isolated
For most of the twentieth century, textbooks described the brain as “immune privileged,” meaning it was largely walled off from the immune cells patrolling the rest of the body. The blood-brain barrier, a tightly sealed layer of cells lining the brain’s blood vessels, was thought to keep immune traffic out except under extreme circumstances like infection or injury. That picture was not entirely wrong, but it was drastically incomplete.
A landmark shift came with the identification of meningeal lymphatic vessels, channels running along the membranes that surround the brain. These vessels carry fluid, immune cells, and waste molecules from the central nervous system to lymph nodes in the neck, providing a direct physical route for immune surveillance of the brain.1PubMed Central. How Do Meningeal Lymphatic Vessels Drain the CNS? Their discovery challenged the long-held dogma that the central nervous system lacks a lymphatic system and does not interact with peripheral immunity.2PubMed Central. The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders The brain does talk to the immune system, constantly. What changed is our awareness of the conversation.
Microglia and Astrocytes Are the Brain’s Own Immune Force
The brain does not need to rely entirely on immune cells from the bloodstream because it has its own. Microglia are specialized neuroimmune cells that reside throughout the brain and spinal cord, constantly surveying their surroundings.3PubMed Central. Microglia, Trem2, and Neurodegeneration They respond to protein clumps, dead neurons, tissue damage, and infection by changing shape and ramping up inflammatory signaling. But their role goes far beyond damage control.
During development, microglia actively prune unnecessary connections between neurons. In the visual system of young mice, microglia engulf excess synaptic inputs through a pathway involving complement proteins, the same molecular tags the body uses elsewhere to mark cells for destruction. Disrupting this pathway led to lasting deficits in how those neural circuits were wired.4Neuron. Microglia Shape Developing Neural Circuits by Active and Activity-Dependent Synaptic Pruning The picture is not uniform across the brain, however. A more recent study found that in the mouse cortex, microglia-dependent complement signaling does not play a major role in synaptic or axonal pruning, suggesting that the mechanisms vary by brain region and developmental stage.5Cerebral Cortex. Microglia complement signaling promotes neuronal elimination and normal brain functional connectivity The broader point stands: the immune system is not merely reacting to damage in the brain. It is helping build the brain in the first place.
Astrocytes, the star-shaped cells that outnumber neurons in many brain regions, also have an immune dimension that has only recently been appreciated. When microglia become activated by injury or disease, they secrete inflammatory molecules that can push astrocytes into a neurotoxic state. These reactive astrocytes lose their normal supportive functions and begin killing neurons and the cells that insulate nerve fibers.6PubMed Central. Neurotoxic reactive astrocytes are induced by activated microglia They also release complement components and chemical signals that may recruit even more immune cells into the brain from the bloodstream.7PubMed Central. Roles of neuropathology-associated reactive astrocytes: a systematic review Follow-up work identified the actual weapon these toxic astrocytes deploy: saturated lipids packaged into particles, not a protein toxin as had long been assumed.8PubMed Central. Neurotoxic reactive astrocytes induce cell death via saturated lipids This cascade from activated microglia to toxic astrocytes to neuronal death now appears in conditions ranging from Alzheimer’s disease to spinal cord injury, making it a central thread in neuroimmunology research.
When the Blood-Brain Barrier Opens the Gate
The blood-brain barrier is not a static wall. Under inflammatory conditions, the cells lining brain blood vessels begin expressing adhesion molecules that act like molecular Velcro, causing circulating immune cells to slow down, stick, and eventually crawl across the barrier into brain tissue.9PubMed Central. Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases This process is tightly regulated under normal conditions, but in diseases like multiple sclerosis it becomes dysregulated, flooding the brain with immune cells that attack its own tissues.
The barrier’s permeability also shifts with age, chronic stress, and systemic infections. When immune cells from the body infiltrate the brain, they can amplify the inflammatory signaling that microglia and astrocytes are already generating, creating a feedback loop. This is one reason why a serious infection or a major surgery can temporarily worsen cognitive function in older adults: the peripheral immune response spills over into the brain through a barrier that is no longer as tight as it once was.
Autoimmune Attacks on the Brain
Some of the most dramatic examples of neuroimmunology in action involve the immune system directly attacking brain tissue. Multiple sclerosis is the most familiar case. In MS, autoreactive immune cells, particularly T cells and B cells, migrate into the central nervous system and target myelin, the insulating sheath around nerve fibers.10PubMed. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis The resulting damage disrupts the electrical signaling that nerves depend on, producing symptoms that range from numbness and vision problems to difficulty walking.
A less well-known but equally striking condition is anti-NMDA receptor encephalitis, in which antibodies attack glutamate receptors at neuronal synapses. The symptoms frequently include psychiatric features, with delusional thinking, mood disturbances, and aggression among the most common presentations.11JAMA Neurology. Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor Encephalitis In a study of over 500 patients, about 4% had purely psychiatric symptoms with no obvious neurological signs, meaning some were initially misdiagnosed with primary psychiatric illness. The condition is treatable with immunotherapy, and the majority of patients in that study recovered fully or substantially once the immune attack was recognized and addressed.12JAMA Neurology. Frequency and Characteristics of Isolated Psychiatric Episodes in Anti–N-Methyl-d-Aspartate Receptor Encephalitis The existence of this disease reshaped how psychiatrists think about the boundary between “neurological” and “psychiatric” illness. If autoantibodies can cause psychosis, some fraction of what clinicians label as psychiatric disease may have an immune origin that is currently going undetected.
The Immune System in Neurodegeneration
Alzheimer’s and Parkinson’s diseases were long considered purely problems of protein misfolding and neuronal death. Neuroimmunology has added a critical layer to that picture. In Alzheimer’s, microglia express a receptor called TREM2 that helps them detect and respond to pathological proteins. Mutations in TREM2 are a recognized genetic risk factor for the disease, and altered TREM2 expression is linked to the degree of abnormal tau protein accumulation in the brain.13PubMed Central. The role of TREM2 in Alzheimer’s disease: from the perspective of Tau In other words, the brain’s immune surveillance system may partly determine whether the hallmark protein tangles of Alzheimer’s get cleared efficiently or spiral out of control.
In Parkinson’s disease, clumps of a protein called alpha-synuclein activate microglia, and that activation feeds back to accelerate the loss of dopamine-producing neurons.14PubMed. Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation The relationship is reciprocal: the protein clumps provoke inflammation, and the inflammation promotes more neuronal death, which releases more protein clumps. A key player in this loop appears to be a molecular complex called the NLRP3 inflammasome, whose activation triggers the release of potent inflammatory signals that drive neurodegeneration.15USURJ: University of Saskatchewan Undergraduate Research Journal. Alpha-synuclein promotes dopaminergic neuron death in Parkinson’s disease through microglial and NLRP3 activation Breaking this feedback loop is now a major therapeutic target in both diseases.
How the Body Talks to the Brain
Neuroimmunology is not only about what happens inside the skull. The brain monitors immune activity throughout the body in real time, and this monitoring has measurable effects on behavior, mood, and cognition.
One of the clearest pathways runs through the vagus nerve, the long nerve that connects the brainstem to the heart, lungs, and gut. The vagus nerve operates a “cholinergic anti-inflammatory pathway” that allows the brain to dial down immune responses in the body’s organs. Stimulating the vagus nerve can prevent the damaging effects of runaway inflammation in experimental models of sepsis, hemorrhagic shock, and arthritis.16PubMed Central. Physiology and immunology of the cholinergic antiinflammatory pathway This reflex works through nicotinic receptors on immune cells, giving the nervous system direct control over immune activation.17PubMed Central. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation Vagus nerve stimulation is already approved for epilepsy and treatment-resistant depression, and researchers are now investigating whether its immune-dampening effects could benefit autoimmune and inflammatory conditions as well.
The gut-brain axis adds another dimension. Gut bacteria produce short-chain fatty acids as metabolic byproducts, and these molecules influence microglia activity in the brain.18PubMed Central. Elucidating the specific mechanisms of the gut-brain axis: the short-chain fatty acids-microglia pathway The specifics of this pathway are still being worked out, but the broad implication is that the composition of your gut microbiome may shape how your brain’s immune cells behave. This is one reason the microbiome has become such a hot topic in neurological research, even though the practical applications remain limited for now.
Infection, Inflammation, and What Lingers Afterward
Anyone who has had the flu knows the feeling: fatigue, foggy thinking, social withdrawal, loss of appetite. These symptoms are not side effects of the virus itself so much as products of the immune response. Pro-inflammatory molecules called cytokines, released by the body to fight infection, act on the brain to produce “sickness behavior,” a coordinated set of behavioral changes that conserve energy and promote recovery. The overlap between sickness behavior and clinical depression is not a coincidence; shared inflammatory pathways underpin both.19PubMed Central. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
What concerns researchers more is what happens after the acute infection clears. In mice infected with influenza, activated microglia persisted in the hippocampus for at least a month after the virus was gone, and the animals showed impairments in spatial learning along with structural changes in hippocampal neurons.20Journal of Neuroscience. Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function This kind of lingering neuroinflammation after a systemic infection offers a plausible framework for post-viral cognitive complaints, a subject that gained enormous public attention during the COVID-19 pandemic. The virus does not need to infect the brain directly; the immune response alone can leave lasting marks.
Maternal Immunity and Neurodevelopment
The neuroimmune relationship begins before birth. Activation of the mother’s immune system during pregnancy, whether from infection, autoimmune flares, or other inflammatory triggers, has been associated with an increased risk of neurodevelopmental conditions in the child, particularly schizophrenia and autism spectrum disorder. Microglia are implicated as potential mediators: because they colonize the developing brain early in gestation, disruptions to their function during critical windows may produce effects that persist into postnatal life.21PubMed Central. The role of microglia in early neurodevelopment and the effects of maternal immune activation
This does not mean that every maternal infection causes a developmental disorder. The associations are statistical, and the absolute risk increase for any individual pregnancy is small. But the research underscores something important: the immune environment a developing brain grows up in matters, and microglia are the bridge between that environment and neural circuit formation. Ongoing work is trying to identify whether specific timing windows or types of immune activation carry the most risk, which could eventually inform public health strategies around infection prevention during pregnancy.
Aging, Senescent Cells, and the Inflamed Brain
Even in the absence of disease, the brain becomes increasingly inflamed with age. Part of the explanation involves cellular senescence: cells that have stopped dividing but refuse to die, instead pumping out inflammatory molecules. Microglia and other brain cells accumulate senescent populations over a lifetime, and the inflammatory signals these cells release contribute to the chronic low-grade neuroinflammation characteristic of the aging brain.22PubMed Central. Cellular Senescence in Brain Aging DNA damage and cellular senescence in both the immune system and the central nervous system contribute to escalating neuroinflammation and cognitive decline during normal aging.23Trends in Neurosciences. Immunology of normal brain aging
An intriguing line of mouse research has shown that clearing senescent cells can reverse some of this decline. When aged mice were treated with drugs that selectively eliminate senescent cells, the microglial population showed reduced activation, inflammatory signaling dropped, and the mice performed measurably better on cognitive tests.24PubMed Central. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice Sleep deprivation compounds the problem by disrupting the glymphatic system, the brain’s waste-clearance machinery, promoting the buildup of neurotoxic metabolites that further stoke inflammation.25PubMed. Sleep deprivation-induced cognitive impairment: Unraveling the role of neuroinflammation The practical implication is straightforward: consistent sleep may be one of the most accessible ways to keep neuroinflammation in check as you age, even if the senolytic drugs being tested in mice are still years from human use.
Therapeutic Frontiers
The clearest clinical success story in neuroimmunology to date involves multiple sclerosis. Monoclonal antibodies targeting the CD20 molecule on B cells have become a cornerstone of MS treatment. These drugs deplete the B cells that contribute to the autoimmune attack on myelin, and they prevent relapses, reduce new brain lesions visible on MRI, and slow disability progression in patients with relapsing forms of MS.26PubMed Central. Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic Anti-CD20 therapy is also the first treatment approach shown to protect against disability worsening in primary progressive MS, a form of the disease that previously had almost no effective options.27PubMed Central. B-cell Therapy for Multiple Sclerosis: Entering an era
Beyond MS, drug developers are targeting the NLRP3 inflammasome, the molecular alarm system that drives destructive inflammation in conditions like Alzheimer’s and Parkinson’s. A small-molecule inhibitor called NIC7 reversed cognitive impairment in a mouse model of Alzheimer’s disease by blocking the inflammasome’s ability to trigger inflammatory signaling.28PubMed. Novel Small-Molecule Inhibitor of NLRP3 Inflammasome Reverses Cognitive Impairment in an Alzheimer’s Disease Model A newer compound, NT-0796, was specifically designed to cross the blood-brain barrier and has entered clinical development as a potential treatment for neuroinflammatory disorders.29PubMed. Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders These are still early-stage efforts, and the gap between a mouse result and a working human treatment remains large. But the trajectory is clear: instead of targeting only the protein clumps or the dying neurons, researchers are now targeting the immune machinery that amplifies the destruction.
Deeper Roots Than We Thought
The intimacy between the nervous and immune systems is not a quirk of mammalian biology. Invertebrates and vertebrates share a common pool of signaling molecules used in both immune and neuroendocrine communication, and sequence comparisons have confirmed that this molecular overlap stretches back hundreds of millions of years.30Trends in Immunology. Ten years after: the common evolutionary origin of the immune and neuroendocrine systems Dedicated immune cells resembling microglia have been found in the nervous systems of annelid worms and vertebrates but not in many other animal groups, suggesting that brain-resident immune cells evolved independently more than once.31Communications Biology. Connecting the nervous and the immune systems in evolution
The fact that multiple animal lineages independently arrived at the same solution, embedding immune cells within the nervous system, says something about how fundamental the need is. Nervous tissue is metabolically expensive and vulnerable to damage; having local immune surveillance was apparently worth reinventing more than once across evolutionary history. For researchers, the evolutionary perspective also opens practical doors: studying simpler organisms with analogous neuroimmune systems can reveal conserved mechanisms that would be harder to untangle in the complexity of the mammalian brain.
The Glial Scar Problem
After a spinal cord injury or a stroke, the brain’s immune response produces a structure called the glial scar around the damaged area. For decades, this scar was viewed almost entirely as an obstacle: a physical and chemical barrier that prevents severed nerve fibers from regrowing.32PubMed Central. Understanding the Role of the Glial Scar through the Depletion of Glial Cells after Spinal Cord Injury Removing or dissolving the scar was a major goal in spinal cord repair research.
That view has grown more complicated. Experiments depleting the glial cells that form the scar have shown that without it, inflammation spreads further, secondary damage worsens, and functional outcomes can actually deteriorate. The scar appears to serve a containment function, walling off the injury site to protect surviving tissue. The problem is not the scar itself but that the immune response gets stuck in a mode that blocks repair after containment is no longer needed. Finding ways to modulate the scar rather than eliminate it, letting it perform its protective role early on and then easing its inhibitory effects later, is one of the trickier challenges in neurotrauma research. It captures something true about neuroimmunology more broadly: the same immune mechanisms that cause damage in one context are often essential for survival in another, and the therapeutic goal is almost never to shut down the immune system entirely but to recalibrate its timing and intensity.